Day One Biopharmaceuticals: Funding, Investors & Team (Oct 2026)
The very first moment Biopharmaceuticals is a biotechnology organization that spotlights on growing new disease treatments for patients, everything being equal. The organization comprehends that advances in malignant growth research currently empower drug engineers to distinguish kids and grown-ups who might profit from a similar medication. They foster new treatments that meet the basic necessities of individuals of any age living with malignant growth beginning from the science of young life disease. The very first moment Biopharmaceuticals likewise centers its endeavors to carry the best medications to families getting the life changing fresh insight about another malignant growth finding and the requirement for a treatment plan. It focuses on programs that can be quickly brought to showcase for both more youthful and more established patients. The's organization will probably permit and gain the most encouraging items from research foundations as well with respect to biotechnology and drug organizations. The very beginning Biopharmaceuticals was established in 2018 and is settled in South San Francisco, CA, USA.
Day One Biopharmaceuticals has raised $303M across 2 funding rounds on record, the most recent a Post-IPO Equity of $173M announced in Jun 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Day One Biopharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Day One Biopharmaceuticals Funding Rounds
Day One Biopharmaceuticals raised $130M in a Series B announced in Feb 2021.
1.3 years later, a Post-IPO Equity of $173M was announced in Jun 2022.
Day One Biopharmaceuticals Founders and Leadership Team
Contact details for the Day One Biopharmaceuticals team: 2 of 2 have an email address on file.
Start 14-day free trial →Day One Biopharmaceuticals Funding Compared to Other Biotechnology Startups
Day One Biopharmaceuticals' latest round of $173M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Day One Biopharmaceuticals in Biotechnology and South San Francisco
Companies Similar to Day One Biopharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Day One Biopharmaceuticals Funding FAQs
What does Day One Biopharmaceuticals do?
The very first moment Biopharmaceuticals is a biotechnology organization that spotlights on growing new disease treatments for patients, everything being equal. The organization comprehends that advances in malignant growth research currently empower drug engineers to distinguish kids and grown-ups who might profit from a similar medication. They foster new treatments that meet the basic necessities of individuals of any age living with malignant growth beginning from the science of young life disease. The very first moment Biopharmaceuticals likewise centers its endeavors to carry the best medications to families getting the life changing fresh insight about another malignant growth finding and the requirement for a treatment plan. It focuses on programs that can be quickly brought to showcase for both more youthful and more established patients. The's organization will probably permit and gain the most encouraging items from research foundations as well with respect to biotechnology and drug organizations. The very beginning Biopharmaceuticals was established in 2018 and is settled in South San Francisco, CA, USA.
How much funding has Day One Biopharmaceuticals raised?
Day One Biopharmaceuticals has raised $303M across 2 rounds on record. The most recent is a Post-IPO Equity of $173M announced in Jun 2022.
When did Day One Biopharmaceuticals last raise funding?
Day One Biopharmaceuticals' most recent funding round on record is a Post-IPO Equity of $173M, announced in Jun 2022.
Who founded Day One Biopharmaceuticals?
FundedIQ lists Samuel Blackman (Founder) at Day One Biopharmaceuticals.
Who is the CEO of Day One Biopharmaceuticals?
Jeremy Bender is listed as CEO at Day One Biopharmaceuticals.
Where is Day One Biopharmaceuticals headquartered?
Day One Biopharmaceuticals is based in South San Francisco, California, United States.
How many employees does Day One Biopharmaceuticals have?
Day One Biopharmaceuticals is in the 51-100 employee band.
How does Day One Biopharmaceuticals' funding compare to other Biotechnology startups?
Day One Biopharmaceuticals' latest round of $173M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Day One Biopharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Day One Biopharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.